Response Biomedical Corp. develops, manufactures and markets the RAMP system, a rapid diagnostics platform that delivers lab quality performance for efficient patient management in acute care settings. RAMP is a global leader in comprehensive acute care testing with a wide range of markers available including Troponin I, CK-MB, NT-proBNP, D-dimer and Procalcitonin. For effective and efficient patient care, RAMP tests aid in the diagnosis of Acute Myocardial Infarction, Heart Failure and Sepsis.
Included in the Export Interest Directory? Yes
Business Needs: Direct Sales, Distributor/Agent/Representative, Investor